HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print December 3, 2007

This Article Full Text (Reprint (PDF)) Supplemental Data All Versions of this Article: jlb.0807586v1 83/3/692    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Farhat, K. Articles by Ulmer, A. J. Search for Related Content PubMed PubMed Citation Articles by Farhat, K. Articles by Ulmer, A. J.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0807586

Received for publication August 31, 2007.
Revised October 30, 2007.
Accepted for publication November 3, 2007.

Article

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling

Katja Farhat ^*, Sabine Riekenberg ^*, Holger Heine ^*, Jennifer Debarry ^*, Roland Lang , Jörg Mages , Ute Buwitt-Beckmann ^*, Kristina Röschmann ^*, Günther Jung , Karl-Heinz Wiesmüller , and Artur J. Ulmer ^*@

*Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany; Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany; Institute of Organic Chemistry, University of Tübingen, Tübingen, Germany; and EMC microcollections GmbH, Tübingen, Germany

^@ To whom correspondence should be addressed. E-mail: ajulmer{at}fz-borstel.de.

	Abstract

TLR are primary triggers of the innate immune system by recognizing various microorganisms through conserved pathogen-associated molecular patterns. TLR2 is the receptor for a functional recognition of bacterial lipopeptides (LP) and is up-regulated during various disorders such as chronic obstructive pulmonary disease and sepsis. This receptor is unique in its ability to form heteromers with TLR1 or TLR6 to mediate intracellular signaling. According to the fatty acid pattern as well as the assembling of the polypeptide tail, LP can signal through TLR2 in a TLR1- or TLR6-dependent manner. There are also di- and triacylated LP, which stimulate TLR1-deficient cells and TLR6-deficient cells. In this study, we investigated whether heterodimerization evolutionarily developed to broaden the ligand spectrum or to induce different immune responses. We analyzed the signal transduction pathways activated through the different TLR2 dimers using the three LP, palmitic acid (Pam)octanoic acid (Oct)₂C-(VPGVG)₄VPGKG, fibroblast-stimulating LP-1, and Pam₂C-SK₄. Dominant-negative forms of signaling molecules, immunoblotting of MAPK, as well as microarray analysis indicate that all dimers use the same signaling cascade, leading to an identical pattern of gene activation. We conclude that heterodimerization of TLR2 with TLR1 or TLR6 evolutionarily developed to expand the ligand spectrum to enable the innate immune system to recognize the numerous, different structures of LP present in various pathogens. Thus, although mycoplasma and Gram-positive and Gram-negative bacteria may activate different TLR2 dimers, the development of different signal pathways in response to different LP does not seem to be of vital significance for the innate defense system.

Key Words: gene expression • macrophages • microarray • signal transduction • receptor-ligand interaction